The New Zealand government has announced it has secured a supply of tecovirimat, the medicine used to treat monkeypox, but was still working to secure a supply of the monkeypox vaccine, known as Jynneos or Imvanex.
Associate Minister of Health Ayesha Verrall said that 504 courses of tecovirimat are expected to be available in the country from late September.
“This medicine will be free and used to treat those who become unwell with MPX (monkeypox),” Verrall said on Aug. 26. “While New Zealand doesn’t currently have any active cases of MPX, and the risk of widespread transmission is low it is important we are prepared.”…